Is Target Stock Too Cheap to Ignore?
The retailer will return to growth at some point, and its dividend is well protected, too.
This 7.5% Yielding Dividend King Manages Tough Times Just Fine
With a historically high dividend yield and a struggling business, investors wonder if this Dividend King is OK to buy.
Looking for More Income? These Great Dividend Stocks Just Gave Their Investors Another Big Raise.
These energy companies have a knack for increasing their dividends.
2 No-Brainer Dividend Stocks to Buy Hand Over Fist
These growing restaurant chains are paying above-average yields.
Bridging Traditional and Decentralized Finance with 21Shares
On today’s episode, ARK Director of Digital Assets Yassine Elmandjra sits down with special guests Ophelia Snyder, the president and co-founder of 21Shares, and Eliézer Ndinga, the head of research at 21Shares.
Artificial bladders shine light on bugs that cause urinary tract infections
A new study reveals that numerous bacterial strains are capable of hiding in the human bladder wall, suggesting why urinary tract infections often persist after treatment.
Increasing workplace flexibility associated with lower risk of cardiovascular disease
Increasing workplace flexibility may lower employees’ risk of cardiovascular disease, according to a new study. In workplaces that implemented interventions designed to reduce conflict between employees’ work and their personal/family lives, researcher…
New interactive evidence-based mapping tool gives policymakers more insight into highly concentrated cannabis products
After conducting the first scoping review of its kind, researchers have developed an evidence-based interactive mapping tool to assist policymakers as they consider regulating the concentration of THC in cannabis products and as more potent products mo…
Scientists tame biological trigger of deadly Huntington’s disease
Huntington’s disease causes involuntary movements and dementia, has no cure, and is fatal. Scientists have now shown they can slow its progression in flies and worms, opening the door to human treatments.
Toward new targeted treatments for rheumatoid arthritis
New research may lead to new targeted treatments for rheumatoid arthritis (RA), an autoimmune disease that causes joint inflammation and destruction.